Clair Obscur: Expedition 33 is full of twists, turns, and world-changing events even before reaching the final act. So, it trusts that you’ve been paying full attention well before the final battle.

Not content to just put out one twisty movie at the holiday season with Wake Up Dead Man, Netflix decided to open the floodgates – pun fully intended – with South Korean disaster movie The Great Flood ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

The first season of HBO's It: Welcome to Derry has come to a close, leaving us with a long list of questions that need to somehow be answered when the show leaps back in time another 27 years for ...

Are you a multitasker, a free spirit, or an overly optimistic planner? Experts say these are some of the traits that explain why some people are always running behind. Some people just seem wired to ...

The afterlife rom-com/fantasy movie Eternity asks a fairly simple question: Which of the two husbands a 90-something woman married during her lifetime is more important to her, the man she lived with ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Volume 1 of the final season of "Stranger Things" is now out, and it's left viewers with a bunch of burning questions. In this article explaining the ending of Stranger Things Season 5, you’ll find ...

This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...